Stockreport

Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement

Protalix BioTherapeutics, Inc. (DE)  (PLX) 
PDF Partnership combines Protalix's rare disease and biologics expertise with Secarna's AI–powered OligoCreator® platform to jointly develop pharmaceutical candidates for ra [Read more]